title: Investigation into the vasospastic mechanisms in the pathogenesis of glaucomatous neuropathy.
abstract: Spasm of blood vessels supplying the optic nerve head is considered one of possible ischaemic mechanisms of glaucomatous optic neuropathy.
  
  
  OBJECTIVE
  The aim of the study was to evaluate the role of two potent and long-acting vasoconstrictors: endothelin-1 (ET-1) and neuropetide Y (NPY) in the pathogenesis of glaucoma by: 1) measurement of plasma ET-1 and NPY concentrations in primary open-angle glaucoma (POAG) patients with high intraocular pressure (HTG patients) and with normal intraocular pressure (NTG patients) at baseline and following peripheral exposure to cold (cold-pressor test), 2) assessment whether changes, if any, in the plasma concentrations of both peptides following the cold-pressor test correlate with visual field defects.
  
  
  METHODS
  The study was conducted in three groups of subjects: 1) HTG patients, 2) NTG patients and 3) controls. All subjects were young and free from any cardiovascular disorders. ET-1 and NPY concentrations in the plasma were measured by radioimmunoassay (ET-1: Amersham International UK, NPY: Peninsula Laboratories INC). The cold-pressor test was performed by immersing the whole hand in ice-cold water (4 degrees C) for 2 minutes. Visual fields were examined using standard automated perimetry (Octopus 101, G-2 programme, normal strategy).
  
  
  RESULTS
  In the NTG patients the mean baseline plasma ET-1 concentration was significantly lower and the mean baseline plasma NPY concentration significantly higher compared to controls. On the other hand, there were no statistically significant differences in the mean baseline peptide levels between the HTG patients and the control subjects. After the cold-pressor test the mean ET-1 concentrations considerably increased in the three groups. The highest increase was seen in the NTG group and it was statistically significant compared to the HTG group and controls. Following the cold-pressor test the mean NPY concentration was significantly decreased in the NTG group, but remained virtually unchanged in the HTG group and controls. In the NTG patients, significant increase in the mean ET-1 concentration and decrease in the mean NPY concentration seen after the cold-pressor test were accompanied by a significant decrease in the mean MS (mean retinal sensitivity) value in the second eye examined after the cold-pressor test, but no correlation was found between changes in the MS values and changes in the ET-1 and NPY concentrations. There were no significant changes in the mean MS values after cold-pressor test in the HTG patients and controls.
  
  
  CONCLUSIONS
  Our findings suggest abnormal neuro-endothelial mechanisms of vascular tone control in NTG patients, related to the effects of ET-1 and NPY, secondary to endothelial dysfunction and to dysregulation of the autonomic nervous system. These abnormalities may involve potentiation of the vasoconstrictive effects of both ET-1 and NPY leading to the optic nerve head ischaemia and subsequent development of visual field defects in the course of normal-tension glaucoma.
authors.affiliation: Ophthalmology Department, Medical Centre of Postgraduate Education, Warsaw, Poland. kl.okulistyki@szpital-orlowskiego.pl
authors.forename: Barbara
authors.initials: B
authors.lastname: Terelak-Borys
authors.forename: Krystyna
authors.initials: K
authors.lastname: Czechowicz-Janicka
mesh_terms: D000328:Adult; D001794:Blood Pressure; D002829:Choroid / Q000098:blood supply*; D019332:Endothelin-1 / Q000097:blood; D005260:Female; D005902:Glaucoma, Open-Angle / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure; D008297:Male; D009478:Neuropeptide Y / Q000097:blood; D009798:Ocular Hypertension / Q000097:blood / Q000150:complications* / Q000503:physiopathology*; D009898:Optic Disk / Q000098:blood supply; D009901:Optic Nerve Diseases / Q000209:etiology* / Q000503:physiopathology*; D011863:Radioimmunoassay; D012039:Regional Blood Flow; D012307:Risk Factors; D014661:Vasoconstriction; D055815:Young Adult
chemical_list: D019332:Endothelin-1; D009478:Neuropeptide Y